Tazemetostat Expanded Access Program for Adults With Epithelioid Sarcoma
Clinical trial NCT04225429 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT04225429
- Sponsor
- Epizyme, Inc.
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.